Marc Girard

7.1k total citations · 1 hit paper
27 papers, 1.9k citations indexed

About

Marc Girard is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marc Girard has authored 27 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 11 papers in Molecular Biology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marc Girard's work include Multiple Sclerosis Research Studies (11 papers), Viral Infections and Immunology Research (8 papers) and Polyomavirus and related diseases (6 papers). Marc Girard is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Viral Infections and Immunology Research (8 papers) and Polyomavirus and related diseases (6 papers). Marc Girard collaborates with scholars based in France, Canada and United States. Marc Girard's co-authors include Pierre Duquette, James Darnell, David Baltimore, Louise Charest, J Pleines, Caroline Masse, Daniel Marc, Michèle Bouloy, Katherine M. Kean and Enric Tello and has published in prestigious journals such as Nucleic Acids Research, Journal of Molecular Biology and Neurology.

In The Last Decade

Marc Girard

27 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.

1993 1.0k citations Marc Girard, Pierre Duquette et al. profile →

Peers

Countries citing papers authored by Marc Girard

Since Specialization

Citations

This map shows the geographic impact of Marc Girard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Girard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Girard more than expected).

Fields of papers citing papers by Marc Girard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Girard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Girard. The network helps show where Marc Girard may publish in the future.

Co-authorship network of co-authors of Marc Girard

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Girard. A scholar is included among the top collaborators of Marc Girard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Girard. Marc Girard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies 2024 ·Therapeutic Advances in Neurological Disorders ·Helmut Butzkueven, Tomáš Kalinčík, Francesco Patti, Mark Slee, Bianca Weinstock‐Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horáková, Eva Havrdová, Anneke van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, (unknown), Tim Spelman, (unknown)	2
2	Prediction of relapse activity when switching to cladribine for multiple sclerosis 2022 ·Multiple Sclerosis Journal ·(unknown), Anneke van der Walt, Mastura Monif, Suzanne Hodgkinson, Sara Eichau, Tomáš Kalinčík, Jeannette Lechner‐Scott, Katherine Buzzard, Olga Skibina, Vincent Van Pesch, Ernest Butler, Julie Prévost, Marc Girard, Jiwon Oh, Helmut Butzkueven, Vilija Jokubaitis	3
3	CLMP Promotes Leukocyte Migration Across Brain Barriers in Multiple Sclerosis 2022 ·Neurology Neuroimmunology & Neuroinflammation ·Antoine Fournier, Stéphanie Zandee, Marc Charabati, Evelyn Peelen, Olivier Tastet, Jorge I. Alvarez, Hania Kébir, Lyne Bourbonnière, Sandra Larouche, Boaz Lahav, Wendy Klément, Fiona Tea, Alain Bouthillier, Robert Moumdjian, Romain Cayrol, Pierre Duquette, Marc Girard, Catherine Larochelle, Nathalie Arbour, Alexandre Prat	9
4	The IL‐27/IL‐27R axis is altered in CD4⁺ and CD8⁺ T lymphocytes from multiple sclerosis patients 2021 ·Clinical & Translational Immunology ·(unknown), Cyril Laurent, (unknown), (unknown), Olivier Tastet, Odile Devergne, Boaz Lahav, Marc Girard, Pierre Duquette, Alexandre Prat, Catherine Larochelle, Nathalie Arbour	10
5	From Baló’s concentric sclerosis to multiple sclerosis: a series of 6 patients 2020 ·Multiple Sclerosis and Related Disorders ·Xavier Ayrignac, Laurent Létourneau‐Guillon, Clarisse Carra‐Dallière, Pierre Duquette, Marc Girard, (unknown), Boaz Lahav, Catherine Larochelle, Alexandre Prat	6
6	Assessing the risk of multiple sclerosis disease-modifying therapies 2019 ·Expert Review of Neurotherapeutics ·Xavier Ayrignac, Philippe‐Antoine Bilodeau, Alexandre Prat, Marc Girard, Pierre Labauge, Jacques Le Lorier, Catherine Larochelle, Pierre Duquette	8
7	Varied effects of dietary carotenoid supplementation on oxidative damage in tissues of two waterfowl species 2019 ·Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology ·Alex E. Mohr, Marc Girard, Melissah Rowe, Kevin J. McGraw, Karen L. Sweazea	1
8	CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis 2019 ·Cellular and Molecular Immunology ·Tessa Dhaeze, Laurence Tremblay, Catherine Lachance, Evelyn Peelen, Stéphanie Zandee, Camille Grasmuck, Lyne Bourbonnière, Sandra Larouche, Xavier Ayrignac, Rose‐Marie Rébillard, Josée Poirier, Boaz Lahav, Pierre Duquette, Marc Girard, Robert Moumdjian, Alain Bouthillier, Catherine Larochelle, Alexandre Prat	36
9	mTOR Regulates Gap Junction Alpha-1 Protein Trafficking in Sertoli Cells and Is Required for the Maintenance of Spermatogenesis in Mice 2016 ·Biology of Reproduction ·Alexandre Boyer, Marc Girard, (unknown), (unknown), (unknown), Marilène Paquet, Raj Duggavathi, Derek Boerboom	62
10	The impacts of urban sprawl on ecological connectivity in the Montreal Metropolitan Region 2016 ·Environmental Science & Policy ·Jérôme Dupras, Joan Marull, Lluís Parcerisa, Francesc Coll, Andrew Gonzalez, Marc Girard, Enric Tello	122
11	‘Doctor, can I stop my medicine?’ Analysis of disease course after stopping disease-modifying therapy in stable MS patients (P5.192) 2015 ·Neurology ·Ilya Kister, Timothy Spelman, Pierre Duquette, Marc Girard, Jeannette Lechner‐Scott, François Grand’Maison, Mark Slee, Suzanne Hodgkinson, Alessandra Lugaresi, Maria Edite Rio, María Trojano, Helmut Butzkueven, Joseph Herbert	3
12	Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. breakdown → 1993 ·Marc Girard, Pierre Duquette, (unknown)	1014
13	A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly 1991 ·Journal of General Virology ·Daniel Marc, Marc Girard, Sylvie van der Werf	29
14	Analysis of putative active site residues of the poliovirus 3C protease 1991 ·Virology ·Katherine M. Kean, Natalya L. Teterina, Daniel Marc, Marc Girard	43
15	Characterization of the 5′ and 3′ ends of viral messenger RNAs isolated from BHK21 cells infected with germiston virus (bunyavirus) 1990 ·Virology ·Michèle Bouloy, Nathalie Pardigon, Pierre Vialat, (unknown), Marc Girard	72
16	A point mutation in the poliovirus polymerase gene determines a complementable temperature-sensitive defect of RNA replication 1989 ·Virology ·Henri Agut, Katherine M. Kean, (unknown), (unknown), James B. Flanegan, Marc Girard	18
17	Modulations of thein vitrotranslational efficiencies of Yellow Fever virus mRNAs: interactions between coding and noncoding regions 1989 ·Nucleic Acids Research ·Andrés Ruiz‐Linares, Michèle Bouloy, Marc Girard, Annie Cahour	21
18	A poliovirus mutant defective for self-cleavage at the COOH-terminus of the 3C protease exhibits secondary processing defects 1988 ·Virology ·Katherine M. Kean, Henri Agut, (unknown), Eckard Wimmer, Marc Girard	20
19	Analysis by electron microscopy of recombinant plasmids carrying poliovirus type-1 cDNA inserts 1981 ·Annales de l Institut Pasteur Virologie ·Marc Girard, (unknown), Sylvie van der Werf, H. Kopecká	1
20	The poliovirus replication complex: Site for synthesis of poliovirus RNA 1967 ·Journal of Molecular Biology ·Marc Girard, David Baltimore, James Darnell	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact